Latest Wellcome Trust Sanger Institute Stories
For the first time, a nationwide project designed to use genetics to diagnose rare diseases will allow recent massive advances in genomics to translate into patient care in the UK’s National Health Service (NHS).
A 50 year old UK man who began to experience distressing symptoms including seizures, headaches, strange smells and memory impairment had his doctors baffled. It took the medical team four years to find and analyze the real cause.
CAMBRIDGE, Massachusetts, November 17, 2014 /PRNewswire/ -- Direct linking between exome data in DECIPHER and European Journal of
Irys System to be employed in research to improve the quality of the human reference genome SAN DIEGO and ST. LOUIS, Oct.
SAN DIEGO, Aug.
Researchers develop new, powerful single-cell technique to study environmental effects on DNA.
In the most comprehensive exploration of the association between genetic variation and human metabolism, researchers have provided unprecedented insights into how genetic variants influence complex disease and drug response through metabolic pathways.
Researchers have found a major piece of genetic evidence that confirms the role of a group of virus-fighting genes in cancer development.
CAMBRIDGE, England, March 16, 2014 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust
Two teams have independently discovered that a single regulatory protein acts as the master genetic switch that triggers the development of male and female sexual forms (termed gametocytes) of the malaria parasite, solving a long-standing mystery in parasite biology with important implications for human health.